WollenbergAGooderhamMKatohN, et al. Patient-reported burden in adults with atopic dermatitis: an international qualitative study. Arch Dermatol Res. 2024;316(7):380. doi:10.1007/s00403-024-03130-w
2.
EyerichKGooderhamMJSilvestreJF, et al. Real-world clinical, psychosocial and economic burden of atopic dermatitis: results from a multicountry study. J Eur Acad Dermatol Venereol. 2024;38(2):340-353. doi:10.1111/jdv.19500
3.
SilverbergJIGooderhamMKatohN, et al. Combining treat-to-target principles and shared decision-making: international expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis. J Eur Acad Dermatol Venereol. 2024;38(11):2139-2148. doi:10.1111/jdv.20229
4.
PrajapatilVSimpsonELThyssenJP, et al. Absolute EASI target in moderate-to-severe atopic dermatitis: analysis of data from the Measure Up 1 and 2 studies. Acta Derm Venereol. 2022;102:35. doi:10.2340/actadv.v102.4587
5.
EichenfieldDZKnappKDClaxtonA, et al. Unmet needs of effective advanced systemic therapies in moderate-to-severe atopic dermatitis patients in the TARGET-DERM AD Registry. Dermatitis. 2025;36(3):244-257. doi:10.1089/derm.2024.0191
